AzurRx appoints board member
Perspectivas América Latina 2023 Emerging Trends & Growth
Insight Weekly: SVB fallout limited; US rents up; renewable natural gas investments flow in
A Cloud Migration Plan for Corporations featuring Snowflake®
Investor Activism Campaigns Hit Record High in 2022
AzurRx BioPharma Inc. appointed Vern Lee Schramm to its board.
A frequent lecturer and presenter in topics related to chemical biology, Schramm has been a consultant and advisor to Pico Pharmaceuticals, Metabalon Biochemistry, Sirtris Scientific and BioCryst Pharmaceuticals Inc.
